Our study provides an explanation for the association in that large percentage of MS patients coexist with NAFLD and that NAFLD and MS share with impaired insulin sensitivity and lipid dyslipidemia10,20. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.